Approval of ‘Cosentyx,’ a new psoriasis treatment

‘Cosentyx(generic name: secukinumab),’ a Novartis’s new psoriasis treatment, has acquired approval. It is a next-generation new drug which will compete with Janssen’s Stelara.

The Ministry of Food and Drug Safety approved 3 types of medicines, such as Cosentyx, Sensoradipen and Pre-filled Syringe, on the 24^th.

The new drug can be administered in medium to severe plaque psoriasis patients requ...